Amicus Therapeutics is Biotechnology Company that helps in the treatment of the rare diseases that affect and weaken the human body. The company maintains in finding possible accurate treatments of several diseases such as the Fabry diseases, Lysosomal Storage Disorder, Pompe disease and other rare conditions. The company helps the ordinary people get the necessary treatment, therapy sessions, and encouragement. Amicus therapeutic uses modern technological equipment’s which facilitate the growth of the business, the attraction of many clients and equally good results. Learn more about job offerings of Amicus Therapeutics at Indeed.
The company is headed by Mr. Bradley l Campbell who is the president of the company. He has excellent leadership skills which have elevated the company’s profile to greater heights. His exceptional managerial ability, values-driven skills have also led the Amicus therapeutic company to collaborate with other organizations for growth and stability. For instance, the Amicus organization has partnered with the GlaxoSmithKline, JCR pharmaceuticals, and many others. These agencies have supported the Amicus therapeutics company regarding finance, growth, and stability.
The Amicus therapeutics company offers different types of services to the patients. For instance, it works with patients’ organizations, individual patient, healthcare consultants and much. The company sponsors for the better healthcare treatments for the patients with the rare diseases. The company also acts as a bridge between patients and their families, their friends and much more. The company’s staff and specialists offer the following services to the patients with the rare diseases. They provide quality therapy sessions for their patients, listen to their complaints and assuring them of better medical treatments and much more.
Following the equality services the Amicus Therapeutics deliver to the patients globally, it also supports the community empowerment, education, healthy living and much. The company gives back to the community especially to the less fortunate who hardly live a comfortable life. Learn more about the company at crunchbase.com.
Tempus is the latest venture of businessman and philanthropist Eric Lefkofsky. His new venture has managed to secure $70 million dollars in its latest series C venture capitalist funding round. The investors in this latest round include Revolution Growth and New Enterprise Associates.
This latest $70 million dollar cash infusion brings the total number of dollars invested in Tempus to date to $130 million. Tempus is now valued at more than $700 million dollars. It was launched in 2015 by Eric Lefkofsky and a business partner.
Eric Lefkofsky serves as the chief executive officer at Tempus. He has also personally invested considerable funds into Tempus at each funding round. Lefkofsky and his business partner are in fact the single biggest investors in the venture so far. Mr. Lefkofsky has also pledged to invest up to $100 million dollars of his own money into Tempus to see it grow and succeed.
It may seem bizarre that Eric Lefkofsky is now investing in and launching a new healthcare company. After all, he became a billionaire by creating companies and investing in the tech sector and not the healthcare sector. Well, Mr. Lefkofsky has seen a close relative of his afflicted with cancer. He saw the limitations firsthand of the amount of information available regarding cancer treatment. This led him to create Tempus.
So what does Tempus actually aim to do? The company aims to use the latest technology to gather and analyze large amounts of medical data that medical doctors and researchers can then use to treat and study cancer. It is hoped that with more access to information, doctors can then more effectively treat patients with cancer. Eric Lefkofsky has said that the field of oncology or the study of cancer, has historically suffered from a lack of data organization and dissemination. Tempus is looking to change that with its new technology. It also looking to help both doctors and patients that are battling cancer.
To further its goal, Eric Lefkofsky has announced major partnerships with prominent healthcare organizations. They include the Mayo Clinic, The Duke University School of Medicine and the Cleveland Clinic. Together Tempus hopes to build a library of medical data that physicians across the country can use to treat chronic disease such as cancer.
Nabors Industries Ltd owns and operates the largest drilling rig fleet that is land-based, in the globe. This fact is enough to show that the company is one of the best across the globe as a result of its operations. It is the leading drilling rigs provider in the United States as well as the leading provider of offshore platform work over. Nabors Industries Ltd offers innovative drilling technology, drilling software, and instrumentation as well as directional drilling operations. In the present world, technology is widely used, and it is clear that Anthony Petrello who is the Chief Executive Officer of Nabors Industries has not been left out. Implementation of technology is one of the aspects that have led to positive progress and success in the company.
Nabors Industries Ltd through its several subsidiaries manufactures and sells its wrenches, top drives, draw works, catwalks as well as other equipment used in drilling and are installed both offshore and onshore drilling rigs. The workforce of the company is highly skilled explaining why the company is gaining a reputation across the globe. The highly skilled workforce enables the company to set new standards for operational excellence as well as transforming the industry. The CEO of the organization Anthony Petrello is an experienced focused and hardworking individual who effectively leads the company. His excellent leadership skills is one of the facets contributing to success in the company. Apart from being an excellent leader he also has a great team of leaders who are committed to their responsibilities and all of them works together as a team to achieve the set goals of the organization.
Life Line Screening is a company based in Independence, Ohio. The company offers preventative screening with the purpose of finding out whether the patients is having a health problem before the condition become too dangerous and starts causing immense problems for the patient. Preventative screening measures are often used by people that are having suspicions and by people that simply wish to get a thorough secure checkup. Often the preventative screening saves people’s lives.
Life Line Screening offers three types of preventative screening. The Ultrasound screening is sent sound waves with a high frequency to the chosen area. The echoes are recorded, and the structures of the body are screened. This type of screening is useful for checking the abdominal area, the joints and the bones, and if the patient has a Carotid artery disease.
There is also the finger-stick blood screening. It is suitable for identifying diabetes and heart disease. There are few kinds of finger-stick blood screenings available. One measures HDL and LDL; another assess for diabetes risk. There is also a type that checks for risk of cardiovascular disease, and one that finds of there is any kind of a liver injury.
The Limited electrocardiograph screening tests for an irregular heartbeat which is a common heart condition. Patients with such a condition have a higher risk of stroke.
Life Line Screening has been around since 1993. The company has expanded and currently provides secure and affordable testing. The technology is state of the art and allows for accurate and quick results. Over the years Life Line Screening has helped millions of people discover all kinds of health problems early enough to prevent any further risk, and in doing so lives have been safe, and patients have been able to walk away being healthy and perfectly safe once again.
Click here to learn more about Life Line Screening.